Leapfrog safety grades in crosshairs as court sides with Tenet hospitals | $15M in Medicare fraud earns chiropractor 43 months

The nonprofit said it intends to appeal the U.S. District Court’s decision, though it will comply with the ruling for now. Five Tenet hospitals filed the lawsuit in April 2025, accusing Leapfrog of issuing ratings via a pay-to-play model.

Teflyon Cameron’s sentence was announced on Monday. She pleaded guilty for her role in a scheme that sent kickbacks to doctors for medically unnecessary orders. The U.S. Department of Justice said the conspiracy went on for “several years."

The request to the court comes a month after the agency settled with Express Scripts, under the condition the company change its wholesale buying practices, pass on manufacturer rebates and support TrumpRx.gov. Now it's up to CVS Caremark and UnitedHealth’s Optum Rx to make deals of their own. 

Clestina Lamai, the surgical technician, claimed in a lawsuit that Iowa Methodist Medical Center removed her from surgery at the request of a racist patient. The case was settled as a jury was set to deliver its verdict, local media reports. 

The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time. 

Dubbed Health100, the application is being launched as a subsidiary of CVS Health, utilizing Google’s cloud infrastructure data access and security. Powered by AI, Health100 is said to be a full assistant to help patients find providers, services and prescriptions, with the aim being to reduce out-of-pocket spending.

Around a third of teens between 13 and 17 years old are involved with sexting—either as senders, receivers or both. Among the senders, around half become victims of unwanted re-sharing. 

Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.

"It is almost a tidal wave of change from the federal level that is going to begin impacting state legislatures across the country. I think folks should probably be aware of that,” said RBMA's Kit Crancer. 

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short.